Rideout; Darryl

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rideout; Darryl.The latest application filed is for "sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications".

Company Profile

2.8.13

Rideout; Darryl - Milford PA
Rideout; Darryl - San Diego CA
Rideout; Darryl - Parkton MD
Rideout; Darryl - Del Mar CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sulfone Compounds And Pharmaceutical Compositions Thereof, And Their Therapeutic Applications App 20220274922 - Dewji; Nazneen ; et al.	2022-09-01
Inhibitors Of Cd40-cd154 Binding App 20220185785 - RIDEOUT; Darryl ; et al.	2022-06-16
Modified Nucleotide Triphosphates For Molecular Electronic Sensors App 20210139959 - Merriman; Barry L. ; et al.	2021-05-13
Analogs Of Cyclobenzaprine And Amitryptilene App 20200230104 - Lederman; Seth ; et al.	2020-07-23
Cryptates And Methods Of Use App 20190284211 - Hale; Michael ; et al.	2019-09-19
Isometheptene isomer Grant 9,403,755 - Lederman , et al. August 2, 2	2016-08-02
Isometheptene Isomer App 20140212486 - LEDERMAN; SETH ; et al.	2014-07-31
Thiazole And Thiadiazole Inhibitors Of Tyrosine Phosphatases App 20080200371 - CHERUVALLATH; Zacharia S. ; et al.	2008-08-21
Thiazole and thiadiazole inhibitors of tyrosine phosphatases Grant 7,381,736 - Cheruvallath , et al. June 3, 2	2008-06-03
2-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine Phosphatases App 20080070867 - Cheruvallath; Zacharia S. ; et al.	2008-03-20
Inhibitors of anthrax lethal factor App 20070197577 - Rideout; Darryl ; et al.	2007-08-23
Thiazole and thiadiazole inhibitors of tyrosine phosphatases App 20060194768 - Cheruvallath; Zacharia S. ; et al.	2006-08-31
Trisubstituted nitrogen modulators of tyrosine phosphatases App 20060135773 - Semple; Joseph E. ; et al.	2006-06-22
Organosulfur inhibitors of tyrosine phosphatases App 20050065118 - Wang, Jing ; et al.	2005-03-24
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias Grant 6,825,226 - Pfahl , et al. November 30, 2	2004-11-30
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias App 20030073745 - Pfahl, Magnus ; et al.	2003-04-17
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias Grant 6,462,064 - Pfahl , et al. October 8, 2	2002-10-08
Inhibitors of anthrax lethal factor activity Grant 6,436,933 - Rideout , et al. August 20, 2	2002-08-20
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents Grant 6,127,415 - Pfahl , et al. October 3, 2	2000-10-03
Therapeutic use of tin diiododeuteroporphyrin Grant 4,692,439 - Rideout , et al. September 8, 1	1987-09-08
Tin diiododeuteroporphyrin and therapeutic use thereof Grant 4,668,670 - Rideout , et al. May 26, 1	1987-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.